#Market News  42 PM / Updated 14 minutes ago BRIEF-Bioverativ Says Regarding Termination Of Merger Deal With Sanofi Under Certain Circumstances Co Will Be Required To Pay Fee Of $326 Mln Reuters Staff 1 Min Read 
Jan 22 (Reuters) - Bioverativ Inc: 
* BIOVERATIV SAYS REGARDING TERMINATION OF MERGER DEAL WITH SANOFI UNDER CERTAIN CIRCUMSTANCES CO WILL BE REQUIRED TO PAY FEE OF $326 MILLION - SEC FILING Source text: ( bit.ly/2DC3sg7 ) Further company coverage: